It's like they aren't even trying to pretend this wasn't written by a pharmaceutical company AI.

@RickiTarr
To be fair, there's a real incentive here.
Advanced therapies take a lot of money to develop.
If the profits aren't there for the first ten years before the patent expires, those expensive therapies won't get developed.

Now, do we *need* those therapies? Are they net positive to society? People with a lot of money, think so... But socialized "best bang for the people's buck" systems might not.

In this way, the US is subsidizing the future health of the rest of the world(!)

@StompyRobot They are making billions in profit, they are charging more than they need to, has nothing to do with R&D.